In vivo, the combination of NaBu and erastin significantly reduces tumor growth and increases lipid peroxidation, with the antitumor effect attributed to ATF3-mediated downregulation of SLC7A11 [168]. The gene discussed is SLC7A11; the disease is neoplasm.